IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$270M
AUM Growth
-$974K
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
70
New
Increased
Reduced
Closed

Top Buys

1
+$7.76M
2
+$7.74M
3
+$6.3M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.21M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$4.49M

Top Sells

1
+$8.6M
2
+$7.18M
3
+$5.83M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.77M
5
WVE icon
Wave Life Sciences
WVE
+$5.63M

Sector Composition

1 Healthcare 98.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$21.4M 7.92%
316,284
+38,000
2
$15.6M 5.78%
85,022
+33,900
3
$13.2M 4.91%
156,800
+53,200
4
$13.2M 4.88%
142,522
-93,000
5
$12.9M 4.79%
98,641
+25,000
6
$12.2M 4.51%
66,000
+42,000
7
$11.6M 4.32%
259,000
+18,507
8
$11.4M 4.23%
744,245
-52,000
9
$9.98M 3.7%
42,700
+33,200
10
$9.48M 3.52%
443,534
+200,000
11
$9.24M 3.43%
25,803
12
$9.11M 3.38%
356,600
+246,600
13
$8.16M 3.03%
475,633
14
$7.3M 2.71%
23,330
-8,300
15
$6.71M 2.49%
79,000
-22,500
16
$6.22M 2.31%
33,996
17
$5.51M 2.04%
64,284
18
$5.32M 1.97%
82,781
+35,000
19
$4.47M 1.66%
146,000
+47,518
20
$4.21M 1.56%
60,900
21
$4.17M 1.54%
187,599
-25,462
22
$3.96M 1.47%
26,100
+12,300
23
$3.08M 1.14%
128,000
24
$3.05M 1.13%
11,700
25
$2.97M 1.1%
25,800
+12,000
1
2 3